ベンチマークドース法を用いた論文

Murata K, Budtz-Jorgensen E, Grandjean P: Benchmark dose calculations for methylmercury-associated delays on evoked potential latencies in two cohorts of children. Risk Anal 22: 465-474, 2002

村田勝敬, 嶽石美和子. 胎児性メチル水銀曝露による小児神経発達影響−Faroe研究を中心に−. 日衛誌 57: 564-570, 2002

Murata K, Sakai T, Morita Y, Iwata T, Dakeishi M: Critical dose of lead affecting delta-aminolevulinic acid levels. J Occup Health 45: 209-214, 2003

Murata K, Weihe P, Budtz-Jorgensen E, Jorgensen PJ, Grandjean P: Delayed brainstem auditory evoked potential latencies in 14-year-old children exposed to methylmercury. J Pediatr 144: 177-183, 2004

Dakeishi M, Iwata T, Ishii N, Murata K: Effects of alcohol consumption on hepatocellular injury in Japanese men. Tohoku J Exp Med 202: 31-39, 2004

Murata K, Sakamoto M, Nakai K, Weihe P, Dakeishi M, Iwata T, Liu X-J, Ohno T, Kurosawa T, Kamiya K, Satoh H: Effects of methylmercury on neurodevelopment in Japanese children in relation to the Madeiran study. Int Arch Occup Environ Health 77: 571-579, 2004

Iwata T, Yano E, Karita K, Dakeishi M, Murata K: Critical dose of lead affecting postural balance in workers. Am J Ind Med 48: 319-325, 2005

Karita K, Yano E, Dakeishi M, Iwata T, Murata K: Benchmark dose of lead inducing anemia at the workplace. Risk Anal 25: 957-962, 2005

村田勝敬, 嶽石美和子: 胎児性メチル水銀曝露の小児発達影響と臨界濃度−セイシェルおよびフェロー諸島の研究を中心に−. 日衛誌 60: 4-14, 2005

Dakeishi M, Murata K, Tamura A, Iwata T: Relation between benchmark dose and no-observed-adverse-effect level in clinical research: effects of daily alcohol intake on blood pressure in Japanese salesmen. Risk Anal 26:115-123, 2006

Murata K, Iwata T, Dakeishi M, Karita K: Lead toxicity: does the critical level of lead resulting in adverse effects differ between adults and children? J Occup Health 51: 1-12, 2009

村田勝敬, 苅田香苗, 堀口兵剛, 岩田豊人, 広瀬明彦: ベンチマークドース法の臨床的基準をもつ健康影響指標への適用. 産衛誌 53: 67-77, 2011


To Top Page